Speeches and presentations

10/01/2023 15:30:00

41st annual JP Morgan Healthcare Conference

Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

30/11/2022 13:00:00

Evercore ISI HealthCONx Conference

Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30^th, 1pm UK / 8:00am ET.

16/11/2022 09:45:00

Jefferies London Healthcare Conference

David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.

28/10/2022 12:00:00

Response to Investor Forum Letter

GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.

21/10/2022 13:00:00

Investor science event: Getting ahead of respiratory syncytial virus in older adults

After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.

16/09/2022 08:15:00

BofA 2022 Global Healthcare Conference

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.

07/09/2022 18:50:00

Citi 17th Annual BioPharma Conference

Roger Connor, President Global Vaccines & Global Health and Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK. 

14/06/2022 14:45:00

dbAccess Global Consumer Conference 2022

Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).

13/06/2022 10:00:00

Goldman Sachs 43rd Annual Global Healthcare Conference..

Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13^th at 10:00pm UK / 5:00pm ET

24/05/2022 14:15:00

UBS Global Healthcare Conference 2022

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24^th at 2:15pm UK / 9:15am ET.​

20/05/2022 14:00:00

JPMorgan CEO Consumer Staples fireside chat series

Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company. 

05/04/2022 15:00:00

ESG Investor Education Event (Environment)

Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.

09/03/2022 16:00:00

UBS Global Consumer and Retail Conference 2022

Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.

07/03/2022 16:10:00

Cowen 42nd Annual Health Care Conference

Hal Barron, Chief Scientific Officer and President R&D, discussed the progress GSK is making in R&D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.

28/02/2022 12:20:00

GSK Consumer Healthcare Capital Markets Day

GSK's Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.

10/02/2022 08:00:00

FCLT Global presents “Investing in Healthcare Innovations: A Case Study of Multi-stakeholder Capitalism in Practice"

Roger Connor, President Global Vaccines & Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10^th at 8:00am ET/1:00pm GMT.  The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.

11/01/2022 12:30:00

JP Morgan Healthcare Conference 2022

Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

06/01/2022 13:00:00

Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.

02/12/2021 12:00:00

Morgan Stanley ESG Insights Conference 2021

Harmony Garges, SVP and Chief Medical Officer ViiV Healthcare, presented at the virtual Morgan Stanley ESG Insights Conference and provided an overview of ViiV’s mission to leave no person living with HIV behind and how it aligns with ViiV’s ESG efforts.

01/12/2021 10:00:00

Redburn CEO conference 2021

Brian McNamara, CEO of GSK Consumer Healthcare, participated in a virtual fireside chat at the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.

29/11/2021 15:00:00

Meet GSK management: getting ahead of HIV

GSK hosted a ‘Meet GSK management’ event on 29 November 2021 at 15:00 GMT / 10:00 EST.

09/11/2021 12:00:00

UBS European Conference 2021

Tobias Hestler, CFO GSK Consumer Healthcare, participated in a virtual fireside chat at the UBS European Conference hosted by analyst Guillaume Delmas.

07/11/2021 17:00:00

Investor science event: ASN Kidney Week 2021

GSK held an investor science event for daprodustat’s ASCEND Phase III programme at 12 noon EST/ 5pm GMT on 7 November 2021.

07/10/2021 12:00:00

The Investor Forum

Sir Jonathan Symonds, Chairman, and Manvinder Singh Banga, Senior Independent Non-Executive Director, participated in an Investor Forum meeting on Thursday 7 October 2021.

06/10/2021 18:00:00

Guggenheim 2nd Annual Vaccine and Infectious Disease Day

Rino Rappuoli, Senior Vice President Global Head of Vaccines R&D, will participate in a fireside chat at Guggenheim’s 2^nd Annual Vaccine and Infectious Disease Day taking place Wednesday 6 October 2021 at 1:00pm ET. 

22/09/2021 12:17:21

Bernstein Annual Pan European Strategic Decisions Conference

Tobias Hestler, CFO for GSK Consumer Healthcare participated in a virtual fireside chat at the Bernstein Annual Pan European Strategic Decisions Conference.

17/09/2021 08:15:00

BofA 2021 Global Healthcare Conference

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 17 September at 0815 BST.

10/09/2021 12:00:00

Barclay’s Global Consumer Staples conference

Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay’s analyst, Iain Simpson.  He provided an overview of the Consumer Healthcare business and our category leading brands. 

09/09/2021 16:25:00

Citi 16th Annual Biopharma Conference

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare participated in a fireside chat at Citi’s 16th Annual Biopharma Conference taking place on Thursday 9 September 2021 at 18:25 UK / 1:25pm EDT. Dr. Smith provided an update on ViiV Healthcare’s progress in advancing HIV science and R&D.

29/06/2021 12:48:17

Guggenheim’s Biopharma Strategy Series

Hal Barron, Chief Scientific Officer and President R&D, joined a virtual fireside chat hosted by Guggenheim analyst Seamus Fernandez at Guggenheim’s Biopharma Strategy Series.

The event, 'Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation' took place Tuesday, 29 June 2021 at 19:00 BST / 14:00 EDT, during which he provided an update on the progress GSK is making in R&D.

23/06/2021 12:57:43

New GSK Investor update

Emma Walmsley, CEO, and other members of CET hosted a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.

10/06/2021 13:01:46

Exane BNP Paribas 23rd European CEO Conference

Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.

08/06/2021 13:11:58

CECP Biopharma Investor Forum

Emma Walmsley, CEO, presented at CECP’s Biopharma Investor Forum on Tuesday 8 June at 8:40 EST/13:40 BST, during which she provided an overview on our approach to ESG. The presentation was followed by a moderated Q&A session.

10/03/2021 13:20:05

Barclays Global Healthcare Conference 2021

Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.

01/03/2021 13:22:01

Cowen 41st Annual Health Care Conference

Hal Barron, Chief Scientific Officer and President R&D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R&D.

11/02/2021 13:26:41

Guggenheim Healthcare Talks 2021

Axel Hoos, GSK Senior Vice-President Oncology R&D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R&D progress.

11/01/2021 13:30:59

39th annual JP Morgan Virtual Healthcare Conference

Hal Barron, Chief Scientific Officer and President R&D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT.  The presentation was followed by a Q&A session. 

05/01/2021 14:25:31

Goldman Sachs 13th Annual Healthcare Unscripted CEOs Conference

Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT

09/12/2020 14:33:01

Morgan Stanley ESG Insights Conference

Phil Thomson, President Global Affairs, hosted a fireside chat at the Morgan Stanley ESG Insights Conference on Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.

01/12/2020 14:35:37

Evercore ISI HealthCONx Conference

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at Evercore ISI HealthCONx Conference on Tuesday, 1 December 2020 at 13:00 GMT / 8:00am EST, during which provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

22/10/2020 14:39:49

Investor and analyst call to discuss RSV vaccines data

GSK held an investor and analyst call hosted by Hal Barron, Chief Scientific Officer and President R&D, Roger Connor, President, GSK Vaccines, and Emmanuel Hanon, SVP and Head of Vaccines R&D, and discussed data on two respiratory syncytial virus (RSV) vaccine candidates to be presented at ID Week.

This event took place on Thursday 22 October at 3:30pm CET / 2:30pm BST / 9:30am EDT.

17/09/2020 14:49:35

BofA Global Healthcare Conference

Emma Walmsley, CEO, hosted a fireside chat at the BofA Global Healthcare Conference on Thursday 17 September at 0815 BST.

09/09/2020 14:51:57

Citi 15th Annual Biopharma Conference

Hal Barron, Chief Scientific Officer and President R&D, will host a fireside chat at the Citi 15th Annual Biopharma Conference taking place Wednesday 9 September 2020 at 16:40 BST/11:40am EDT, during which he will provide an update on the progress GSK is making in the R&D pipeline.

09/07/2020 15:00:53

Investor and analyst call to discuss HIV Prevention Treatment Network 083 study

GSK held an investor/analyst call hosted by David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO, ViiV Healthcare and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare to discuss the final efficacy analysis from the global HIV Prevention Treatment Network (HPTN) 083 study evaluating investigational long-acting cabotegravir for HIV prevention.

This event took place on: Thursday 9 July at 14:00 BST / 09:00 EDT

13/02/2020 15:09:52

Guggenheim Healthcare Talks Idea Forum, New York City

Axel Hoos, Senior Vice-President Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum, Oncology Day, held in New York City on Thursday, February 13th, during which he provided an update on GSK Oncology R&D progress.

14/01/2020 15:13:01

38th annual JP Morgan Healthcare Conference, San Francisco

Emma Walmsley, CEO, presented at the 38th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 14 January, and provided an overview of GSK’s priorities and the progress the company made during 2019.  The presentation was followed by a Q&A session. 

17/12/2019 15:26:35

Investor and Analyst call from DREAMM-2 data

On Tuesday, 17 December 2019 at 17:00 GMT / 12:00 EST, Hal Barron, Chief Scientific Officer and President of R&D, Luke Miels, President Pharmaceuticals and Axel Hoos, SVP Oncology R&D hosted an investor/analyst conference call to discuss GSK’s pivotal DREAMM-2 data on belantamab mafodotin (GSK’916).

30/09/2019 15:40:22

Investor and Analyst call from ESMO 2019

On Monday, 30 September 2019, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals hosted an investor conference call following the presentation of the PRIMA data on Zejula (niraparib) and the INDUCE-1 data on GSK’609 (ICOS) at the 2019 European Society for Medical Oncology (ESMO) congress. The call also featured participation from an external expert in ovarian cancer and other GSK senior oncology leaders.

26/09/2019 16:08:47

GSK Vaccines Investor Event

Roger Connor, President, GSK Vaccines, hosted an educational session on GSK’s Vaccines business at our manufacturing site in Wavre, Belgium on Thursday 26 September at 13:30 CET / 12:30 BST / 7:30 EDT.

12/06/2019 16:19:23

Goldman Sachs’ 40th Annual Global Healthcare Conference, California

Hal Barron, Chief Scientific Officer and President R&D, hosted a fireside chat at Goldman Sachs’ 40^th Annual Global Healthcare Conference, which took place in Rancho Palos Verdes, California on Wednesday 12 June, during which he has provided an update on the progress being made in GSK’s R&D organisation.

06/06/2019 16:27:10

Jefferies 2019 Healthcare Conference, New York

David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, and Deborah Waterhouse, CEO of ViiV Healthcare, hosted a fireside chat at the Jefferies 2019 Healthcare Conference in New York on Thursday 6 June, during which they provided an update on the progress GSK and ViiV Healthcare have made this year.

04/06/2019 16:29:56

Bernstein Consumer Healthcare & Nutrition Seminar, London

Tobias Hestler, CFO GSK Consumer Healthcare, hosted a fireside chat at the Bernstein Consumer Healthcare & Nutrition Seminar in London on Tuesday 4 June during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

30/04/2019 16:44:38

ViiV Healthcare analyst call

David Redfern, Chairman ViiV Healthcare, Deborah Waterhouse, CEO ViiV Healthcare and Dr Kimberly Smith, VP Global Research & Medical Strategy hosted a ViiV Healthcare analyst call on Tuesday 30 April to discuss ViiV Healthcare’s recent regulatory activities and provide an update on the pipeline.

12/03/2019 16:54:01

Cowen & Co. 39th Annual Health Care Conference, Boston

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at the Cowen & Co. 39th Annual Health Care Conference 2019 in Boston on Tuesday 12 March, during which he provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

28/02/2019 16:56:23

SVB Leerink Global Healthcare Conference, New York

Brian McNamara, CEO GSK Consumer Healthcare, hosted a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference that took place in New York City on Thursday 28 February during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

14/02/2019 17:00:55

Guggenheim Healthcare Talks Idea Forum, New York

Axel Hoos, SVP Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum - Oncology Day held in New York City on Thursday 14 February during which he provided an update on GSK Oncology R&D progress.

08/01/2019 17:08:23

37th annual JP Morgan Healthcare Conference, San Francisco

Emma Walmsley, CEO, gave a presentation at the 37th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 8 January, providing an overview of GSK’s priorities and the progress the company made during 2018.

19/12/2018 17:14:38

Analyst call on formation of new Consumer Healthcare JV

On Wednesday 19 December 2018, GSK announced an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Brian McNamara, CEO GSK Consumer Healthcare and Simon Dingemans, Chief Financial Officer.

10/12/2018 17:31:20

ViiV Meet the Management, London

David Redfern, Chairman ViiV Healthcare and Deborah Waterhouse, CEO ViiV Healthcare along with members of the ViiV Healthcare leadership team hosted a ViiV Healthcare Investor Event on Monday 10 December in London. The event included presentations from David, Deborah, Dr Kimberly Smith Global Research & Medical Strategy, Eric Dube Head of North America and Dr John Pottage Chief Scientific & Medical Officer and was followed by a Q&A session

05/12/2018 17:41:52

Citi 2018 Global Healthcare Conference, New York

Hal Barron, Chief Scientific Officer and President, R&D hosted a fireside chat at the Citi 2018 Global Healthcare Conference held in New York City on Wednesday 5 December, in which he provided an overview of GSK’s R&D priorities and progress made during 2018.

03/12/2018 17:45:53

Analyst call on agreement to acquire TESARO

On Monday, 3 December 2018, GSK announced an agreement to acquire TESARO, an oncology-focused company based in the US. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer, Dr Hal Barron, Chief Scientific Officer and President R&D, and Luke Miels, President, GSK Global Pharmaceuticals.

28/11/2018 17:52:24

Evercore ISI HealthConX Conference, Boston

Deborah Waterhouse, CEO, and Dr Kimberly Smith, Head of Global Research and Medical Strategy, ViiV Healthcare, hosted a fireside chat at the Evercore ISI HealthConX Conference held in Boston, Massachusetts on Wednesday 28 November, during which they provided an overview of ViiV’s priorities and progress made during 2018.

23/10/2018 09:32:12

Investor and Analyst call on GSK’165 aGM-CSF data presented at ACR

On Tuesday, 23 October 2018, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals hosted an investor conference call following the presentation of efficacy and safety data on GSK3196165, GSK's anti-GM-CSF antibody in development for Rheumatoid Arthritis at the 2018 American College of Rheumatology (ACR). The call also featured participation from an external expert in rheumatology and GSK’s Medicine Development Lead for GSK’165.

21/09/2018 09:41:32

Consumer Healthcare investor event, New Jersey

Brian McNamara, CEO GSK Consumer Healthcare, and members of his leadership team hosted an investor event to review the Consumer Healthcare business. This event included a tour of our Shopper Science, Consumer Sensory and R&D labs, as well as presentations from Brian McNamara, Marc Speichert, SVP Digital and Richard Slater, SVP R&D, followed by a Q&A session.

20/09/2018 09:50:25

CECP CEO Investor Forum

Emma Walmsley, CEO, spoke at CECP’s CEO Investor Forum on Thursday 20 September 2018 about the steps we are taking to build trust – one of our three long-term priorities – and drive sustainable business performance.

13/09/2018 09:53:09

Bank of America Merrill Lynch Global Healthcare Conference, London

Emma Walmsley, CEO, gave a presentation at the Bank of America Merrill Lynch Global Healthcare Conference in London on Thursday 13 September 2018 in which she provided an overview of GSK’s priorities and progress made during 2018.

24/07/2018 09:59:41

GEMINI Results of HIV 2 Drug Regimen Investor & Analyst Update

On Tuesday, 24 July 2018, GSK hosted an investor conference call following the presentation of the full set of scientific and clinical data on GSK’s 2 drug regimen of dolutegravir plus lamiviudine (GEMINI studies) in treatment naïve HIV patients at the 22nd International AIDS Conference.

The call was hosted by David Redfern, GSK Chief of Strategy and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO of ViiV Healthcare, John Pottage, Chief Scientific & Medical Officer of ViiV Healthcare, and Kimberly Smith, VP Global Research & Medical Strategy of ViiV Healthcare.

13/06/2018 10:07:30

Goldman Sachs 39th Annual Healthcare Conference, California

David Redfern, Chief Strategy Officer, hosted a fireside chat at the Goldman Sachs 39th Annual Healthcare Conference in Rancho Palos Verdes, California on Wednesday 13 June, in which he provided an overview of GSK’s priorities and progress made during 2018.

06/06/2018 10:21:11

Jefferies 2018 Healthcare Conference, New York City

David Redfern, Chief Strategy Officer, hosted a fireside chat at the Jefferies 2018 Healthcare Conference in New York City on Wednesday 6 June, in which he provided an overview of GSK’s priorities and progress made during 2018.

27/03/2018 10:23:43

Consumer Healthcare Update, London

On Tuesday, 27 March 2018, GSK reached an agreement with Novartis to acquire full ownership of the Consumer Healthcare business. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer and Brian McNamara, CEO, Consumer Healthcare.

09/01/2018 10:48:26

36th annual JP Morgan Healthcare Conference, San Francisco, US

Emma Walmsley, CEO, gave a presentation at the 36th annual JP Morgan Healthcare Conference in San Francisco about our business outlook, as well as our latest product approvals and advances in our pipeline.

12/12/2017 10:56:02

GSK Oncology Investor & Analyst Update

On Tuesday, 12 December 2017, GSK hosted an investor conference call following the presentation of scientific and clinical data on GSK2857916, GSK's anti-BCMA (B-cell Maturation Antigen) antibody-drug conjugate presented at the 59th American Society of Hematology (ASH) annual meeting.

The call was hosted by Luke Miels, President, GSK Global Pharmaceuticals and Axel Hoos, SVP and Therapy Area Head of Oncology R&D. The call also featured participation from an external expert in multiple myeloma.

07/12/2017 11:02:37

Citi Global Healthcare Conference, New York

Axel Hoos, SVP – Oncology R&D, participated in a fireside chat at the Citi Global Healthcare Conference on December 7 in New York.

30/11/2017 11:10:14

Evercore conference, Boston

David Redfern, Chief Strategy Officer and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO of ViiV Healthcare and Kim Smith, Vice President, Global Medical Strategy, ViiV Healthcare, participated in a fireside chat at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference in Boston on Thursday, November 30.

29/11/2017 11:12:04

Consumer Healthcare investor event

Brian McNamara, CEO GSK Consumer Healthcare, and members of his leadership team hosted an investor event to review the Consumer Healthcare business. This event included a tour of our Shopper Science and Consumer Sensory labs, as well as presentations from Brian McNamara and Richard Slater, SVP, R&D Consumer Healthcare, followed by a Q&A session.

26/07/2017 11:20:23

Investor event, London 2017

The investor event outlined the Group’s key priorities including presentations from Emma Walmsley, CEO, and Simon Dingemans, CFO.

08/03/2017 11:36:45

Cowen 37th Annual Healthcare Conference

Axel Hoos, SVP – Oncology R&D, gave a presentation at the Cowen and Company 37^th Annual Health Care Conference  in Boston. Axel provided an overview of GSK’s Oncology strategy and pipeline.

15/02/2017 11:44:49

Investor event at CROI 2017, Seattle

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer John Pottage, hosted an investor event following the presentation of the SWORD Phase III data at the Conference on Retroviral and Opportunistic Infections.

10/01/2017 11:56:53

35th annual JP Morgan Healthcare Conference, San Francisco, USA

Dr Patrick Vallance, President, R&D gave a presentation at the 35th annual JP Morgan Healthcare Conference in San Francisco, providing an overview of the company’s pharmaceutical pipeline.

29/11/2016 13:00:39

Meet the Vaccines management

Luc Debruyne and his leadership team hosted an investor event to review the Vaccines business. This event included a tour of the Wavre site, presentations from Luc Debruyne, Thomas Breuer, Manu Hanon and John McGrath, followed by a Q&A session.

19/09/2016 13:10:28

HIV and ViiV Healthcare presentation to Goldman Sachs

Seminar on the evolving scientific and commercial landscape for HIV and ViiV Healthcare. Presentation by Dr Dominique Limet and Dr John Pottage followed by a Q&A session.

02/09/2016 13:17:46

Meet The Respiratory Management event

Prior to the 2016 ERS conference, senior respiratory leaders Eric Dube, Neil Barnes and Dave Allen hosted an investor event with presentations and a Q&A session to review the Respiratory business.

08/06/2016 13:26:31

Goldman Sachs 37th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, participated in a fireside chat to discuss progress on GSK’s business strategy and addressed questions before a large group of investors at the Goldman Sachs Conference in California on Wednesday, 8 June 2016.

24/02/2016 13:30:20

Citi Healthcare Bus Tour, New York

Dr. Axel Hoos, SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno-Oncology, hosted an investor event organized by Citi at their offices in New York. Axel provided an overview of GSK’s strategy and pipeline in Immuno-Oncology.

10/02/2016 13:35:04

Leerink Partners 5th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10 in New York. Simon provided an overview of GSK’s 2015 full year results and outlook for the future. The webcast of the event will be archived for 90 days.

12/01/2016 13:39:39

34th Annual JP Morgan Healthcare Conference, San Francisco USA

Andrew Witty, CEO, gave a presentation at the 34th Annual JP Morgan Healthcare Conference in San Francisco, providing an overview of progress the company has made during 2015.

18/12/2015 13:46:19

David Redfern

David Redfern, Chief Strategy Officer, discusses the two transactions with Bristol-Myers Squibb to acquire their late-stage HIV pipeline assets and also their pre-clinical and discovery stage research assets.

03/11/2015 13:56:19

R&D event

On Tuesday 3 November, we hosted an event focusing on our R&D pipeline. This provided a unique insight into the innovative medicines and vaccines that GSK is developing for the future.

06/05/2015 15:08:15

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

06/05/2015 14:42:53

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

13/01/2015 15:18:18

33rd Annual JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer, gave a presentation at the 33th Annual JP Morgan Healthcare Conference in San Francisco.

19/09/2014 15:27:07

Bank of America Merrill Lynch Global Healthcare Conference, London UK

Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London on 19th September 2014. Simon provided an overview of the recent results and the shape of the company going forward.

24/02/2014 15:37:03

Citi Global Healthcare Conference, New York USA

Andrew Witty, CEO, presented at the Citi Global Healthcare Conference on February 24, 2014 in New York. Andrew opened with a few minutes of brief remarks followed by a 'fireside chat' question and answer session.

24/02/2014 15:31:08

Investor Event at ERS 2014, Munich

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A session based on data presented at ERS.

14/01/2014 15:38:33

32nd Annual JP Morgan Healthcare Conference, San Francisco USA

Simon Dingemans, Chief Financial Officer, gave a presentation at the 32nd Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing the company’s strategy.

06/12/2013 15:49:10

Leerink Swann PolarXpress, Philadelphia

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event organized by Leerink Swann at the GSK offices in Philadelphia.

22/08/2013 15:52:08

North Carolina CEO Forum

Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.

12/06/2013 15:56:18

Goldman Sachs 34th Annual Global Healthcare Conference, California USA

David Redfern, Chief Strategy Officer, gave a fireside chat on GSK’s business strategy and addressed questions in front of a large group of US investors at the Goldman Sachs Conference in California on Wednesday 12 June 2013.

21/05/2013 15:59:26

Investor Event at ATS 2013, Philadelphia

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a short presentation and Q&A session based on data presented at ATS.

13/02/2013 16:12:11

Leerink Swann Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Swann Global Healthcare Conference on Wednesday, February 13 in New York.  Simon provided an overview of GSK’s 2012 full year results and outlook for the future.

09/01/2013 16:17:11

Late-stage pipeline review - Patrick Vallance

Patrick Vallance, President, Pharmaceutical R&D gave a presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Patrick provided a review of the progress being made on the late stage pipeline.

04/12/2012 16:22:01

Late-stage pipeline review - Sir Andrew Witty, Dr Moncef Slaoui, and Dr Patrick Vallance

Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.

05/11/2012 16:27:14

Annual Pharmaceutical Regulatory and Compliance Congress

Deidre Connelly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.

01/10/2012 16:32:56

Investor Meeting at ESMO, Vienna

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.

27/07/2012 16:37:12

Investor Meeting at IAC, Washington

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).

09/06/2012 16:40:57

Investor Meeting at ADA, Philadelphia

Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.

04/06/2012 16:46:02

Investor Meeting at ASCO, Chicago

Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting.

15/05/2012 16:49:25

World Affairs Council, Philadelphia

Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at the World Affairs Council (WAC) in Philadelphia about how the challenges and opportunities facing the pharmaceutical business.

29/03/2012 16:53:11

R&D Seminar

Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive.

21/03/2012 17:04:15

PharmEHR Summit, Philadelphia

Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape.

10/01/2012 17:17:42

Annual JP Morgan Healthcare Conference

Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco.  Simon provided an overview of the progress being made in implementing GSK’s strategy.

01/12/2011 17:20:55

Core Earnings Reporting

Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.

14/11/2011 17:31:17

Credit Suisse Healthcare Conference, Hong Kong

Abbas Hussain, President, Emerging Markets & Asia Pacific gave a presentation at the Credit Suisse Asia Healthcare Conference in Hong Kong.  Abbas provided an overview of GSK's emerging markets strategy.

05/05/2011 17:34:47

Bernstein Conference, New York

Adrian Rawcliffe, SVP Finance North American Pharmaceuticals, presented at the Bernstein Pharma Conference: “Pharmaceutical R&D Productivity: Diagnosing the Problem & Searching for Solutions” in New York City. The conference was attended by over 100 investors. Ad discussed GSK’s R&D Strategy and its Focus on Return on Investment.

23/03/2011 17:41:06

Citi’s Seminar in London on Vaccines in Emerging Markets

Martin Andrews, SVP – Global Vaccines Centre of Excellence, GSK Biologicals, gave a presentation on GSK’s vaccines business at Citi’s Seminar in London on Vaccines in Emerging Markets.

17/03/2011 17:43:45

Andrew Witty presents to the US State Department

GSK CEO Andrew Witty presented at the United States Department of State symposium, “The Role of Innovation in Addressing Global Health”. In his address, which was convened to discuss advances and ways of working together to overcome diseases of the developing world, Andrew expanded upon GlaxoSmithKline’s commitments in this area.

10/03/2011 17:49:39

Presentation to investors

Abbas Hussain, President, Emerging Markets, gave a presentation to a small group of investors, where he provided an overview of GSK's emerging markets strategy.

08/03/2011 17:53:55

Cowen and Company 31st Annual Health Care Conference

Patrick Vallance, SVP – Medicines Discovery and Development, gave a presentation at the Cowen and Company 31st Annual Health Care Conference in Boston. Patrick provided an overview of GSK’s R&D Strategy and its Focus on Return on Investment.

21/02/2011 17:58:02

CED Biotech/Life Science Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the CED Biotech/Life Science Conference in Raleigh, Durham, on 21 February 2011.

10/02/2011 09:31:26

The Economist Pharma Summit

David Redfern, GSK Chief Strategy Officer, was one of the two keynote speakers at The Economist Pharma Summit Reinventing Pharma for a New Generation  on 10 February 2011 in London. He outlined GSK’s strategic priorities, our innovative approach to pricing and the value of our late stage pipeline coupled with our ongoing efforts to drive the effectiveness of R&D.

24/01/2011 09:37:30

CBI 8th Annual Pharmaceutical Compliance Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the 8th annual Center for Business Intelligence (CBI) pharmaceutical compliance conference on 24 January. Deirdre spoke about what the pharmaceutical industry must do to build trust.

12/01/2011 09:44:37

JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer at GlaxoSmithKline, gave a presentation at the 29th Annual JP Morgan Healthcare Conference in San Francisco.  David provided an overview of the progress being made in implementing GSK’s strategy.

09/12/2010 09:50:05

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4.

02/12/2010 09:54:45

Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference

The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry.

01/12/2010 09:59:16

CLSA China Conference

Mark Reilly, GM, Pharmaceuticals China & Hong Kong, gave a presentation at the CLSA China Conference on December 1 in New York City. Mark gave an update on GSK’s strategy and progress in its pharmaceuticals business in China.

22/11/2010 10:02:55

CEO Andrew Witty featured in The World in 2011

In The World in 2011, published in November 2010 by The Economist, Andrew Witty, CEO of GlaxoSmithKline, calls on the pharmaceutical industry to do more with less—and still be innovative.

19/11/2010 10:06:22

Mind the Medicine Gap

In this Open University programme on global access to medicines, Jon Pender of GlaxoSmithKline discusses the importance of intellectual property and why it is a critical mechanism to allow companies to generate funds for reinvestment to help create the medicines of the future.The programme also discusses how pharmaceutical companies can help to tackle neglected tropical diseases and improve access to medicines in developing nations.

10/11/2010 10:15:50

Credit Suisse Healthcare Conference, Phoenix, AZ

Deirdre Connelly, President, North America Pharmaceuticals, gave a presentation at the 2011 Annual Credit Suisse Healthcare Conference in Phoenix, AZ on 10 November. The presentation was attended by institutional investors and portfolio managers. Deirdre provided an overview of GSK’s US Pharmaceuticals business.

10/11/2010 10:09:44

Credit Suisse Healthcare Conference

Andrew Witty, Chief Executive Officer, gave a presentation at the 2010 Annual Credit Suisse Health Care Conference in Phoenix, AZ. The presentation was attended by over 100 institutional investors and portfolio managers. Andrew provided an overview of the progress being made in implementing the company's strategy.

22/09/2010 10:21:27

Sanford C. Bernstein Pan-European Strategic Decisions Conference

Julian Heslop (CFO) gave a presentation at the Sanford C. Bernstein 7th Pan-European Strategic Decisions Conference in London.  Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future.

17/09/2010 10:25:20

Bank of America/Merrill Lynch Global Healthcare Conference

Julian Heslop (CFO) gave a presentation at the BoA/Merrill Lynch Healthcare Conference in London.  Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future.

23/06/2010 10:28:14

Investor Meeting with John Clarke, President, Worldwide Consumer Healthcare

John Clarke (President, Worldwide Consumer Healthcare), along with senior members of his management team, presented on GSK's Consumer Healthcare business.

21/06/2010 10:31:56

Investor Visit to GSK Biologicals, Wavre, Belgiu

Dr Thomas Breuer (Senior Vice President, Head of Global Development, GSK Biologicals) presented on GSK’s vaccines business.

16/06/2010 10:46:16

Goldman Sachs Thirty-First Annual Health Care Conference in California

Andrew Witty gave the keynote speech regarding the Pharmaceutical Industry and GSK's strategy at the Goldman Sachs Thirty-First Annual Health Care Conference in California.

01/06/2010 10:50:33

Slides Presented at Investor Meetings in June

This is a general slide deck presented at investor meetings during June 2010.

26/05/2010 10:53:10

2010 Citi Investment Research Global Health Care Conference in New York

Simon Harford (SVP, Finance, Emerging Markets) participated on a panel at the 2010 Citi Investment Research Global Health Care Conference in New York. The panel was entitled "The Opportunities and Challenges of Emerging Markets for Health Care"

12/01/2010 10:55:53

JP Morgan 28th Annual Healthcare Conference

Andrew Witty (CEO) gave a presentation to investors at the JP Morgan 28th Annual Healthcare Conference in San Francisco. Andrew provided an overview of the progress being made in implementing the company's strategy.